nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP3A4—Temozolomide—brain cancer	0.0748	0.366	CbGbCtD
Rufinamide—CYP3A4—Lomustine—brain cancer	0.0636	0.311	CbGbCtD
Rufinamide—CYP2E1—Etoposide—brain cancer	0.0507	0.248	CbGbCtD
Rufinamide—GRM5—telencephalic ventricle—brain cancer	0.0329	0.0914	CbGeAlD
Rufinamide—SCN8A—cerebellar cortex—brain cancer	0.0318	0.0884	CbGeAlD
Rufinamide—GRM5—ganglion—brain cancer	0.0205	0.0569	CbGeAlD
Rufinamide—GRM5—hindbrain—brain cancer	0.0155	0.0431	CbGeAlD
Rufinamide—CYP3A4—Etoposide—brain cancer	0.0154	0.0751	CbGbCtD
Rufinamide—SCN11A—ganglion—brain cancer	0.0152	0.0422	CbGeAlD
Rufinamide—Status epilepticus—Temozolomide—brain cancer	0.0132	0.0393	CcSEcCtD
Rufinamide—Balance disorder—Procarbazine—brain cancer	0.00943	0.028	CcSEcCtD
Rufinamide—Contusion—Lomustine—brain cancer	0.00931	0.0276	CcSEcCtD
Rufinamide—GRM5—brainstem—brain cancer	0.00889	0.0247	CbGeAlD
Rufinamide—SCN8A—hindbrain—brain cancer	0.00873	0.0243	CbGeAlD
Rufinamide—GRM5—telencephalon—brain cancer	0.00789	0.0219	CbGeAlD
Rufinamide—SCN10A—ganglion—brain cancer	0.0077	0.0214	CbGeAlD
Rufinamide—Nystagmus—Procarbazine—brain cancer	0.00722	0.0214	CcSEcCtD
Rufinamide—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00679	0.0201	CcSEcCtD
Rufinamide—SCN1A—hindbrain—brain cancer	0.0066	0.0184	CbGeAlD
Rufinamide—SCN2A—hindbrain—brain cancer	0.00606	0.0168	CbGeAlD
Rufinamide—GRM5—midbrain—brain cancer	0.00567	0.0158	CbGeAlD
Rufinamide—Nocturia—Procarbazine—brain cancer	0.00556	0.0165	CcSEcCtD
Rufinamide—Ataxia—Lomustine—brain cancer	0.00554	0.0165	CcSEcCtD
Rufinamide—GRM5—spinal cord—brain cancer	0.00553	0.0154	CbGeAlD
Rufinamide—SCN8A—brainstem—brain cancer	0.005	0.0139	CbGeAlD
Rufinamide—GRM5—endocrine gland—brain cancer	0.00498	0.0138	CbGeAlD
Rufinamide—GRM5—head—brain cancer	0.00491	0.0137	CbGeAlD
Rufinamide—GRM5—central nervous system—brain cancer	0.00448	0.0125	CbGeAlD
Rufinamide—SCN8A—telencephalon—brain cancer	0.00444	0.0123	CbGeAlD
Rufinamide—GRM5—cerebellum—brain cancer	0.00438	0.0122	CbGeAlD
Rufinamide—SCN11A—spinal cord—brain cancer	0.0041	0.0114	CbGeAlD
Rufinamide—SCN1A—brainstem—brain cancer	0.00378	0.0105	CbGeAlD
Rufinamide—Diplopia—Procarbazine—brain cancer	0.00374	0.0111	CcSEcCtD
Rufinamide—SCN11A—head—brain cancer	0.00365	0.0101	CbGeAlD
Rufinamide—Disturbance in attention—Temozolomide—brain cancer	0.0036	0.0107	CcSEcCtD
Rufinamide—GRM5—brain—brain cancer	0.00356	0.0099	CbGeAlD
Rufinamide—Ataxia—Procarbazine—brain cancer	0.00352	0.0104	CcSEcCtD
Rufinamide—SCN2A—brainstem—brain cancer	0.00347	0.00965	CbGeAlD
Rufinamide—SCN1A—telencephalon—brain cancer	0.00336	0.00933	CbGeAlD
Rufinamide—SCN11A—central nervous system—brain cancer	0.00333	0.00926	CbGeAlD
Rufinamide—Gait disturbance—Carmustine—brain cancer	0.00331	0.00981	CcSEcCtD
Rufinamide—Infection—Carboplatin—brain cancer	0.00329	0.00977	CcSEcCtD
Rufinamide—Coordination abnormal—Carmustine—brain cancer	0.00329	0.00975	CcSEcCtD
Rufinamide—Gait disturbance—Temozolomide—brain cancer	0.00319	0.00948	CcSEcCtD
Rufinamide—Leukopenia—Lomustine—brain cancer	0.00318	0.00944	CcSEcCtD
Rufinamide—SCN9A—pituitary gland—brain cancer	0.00318	0.00884	CbGeAlD
Rufinamide—Coordination abnormal—Temozolomide—brain cancer	0.00318	0.00943	CcSEcCtD
Rufinamide—SCN7A—endocrine gland—brain cancer	0.00314	0.00874	CbGeAlD
Rufinamide—Urinary incontinence—Carmustine—brain cancer	0.00312	0.00925	CcSEcCtD
Rufinamide—SCN8A—spinal cord—brain cancer	0.00311	0.00865	CbGeAlD
Rufinamide—SCN7A—head—brain cancer	0.0031	0.00863	CbGeAlD
Rufinamide—SCN2A—telencephalon—brain cancer	0.00308	0.00857	CbGeAlD
Rufinamide—Urinary incontinence—Temozolomide—brain cancer	0.00301	0.00894	CcSEcCtD
Rufinamide—Pollakiuria—Procarbazine—brain cancer	0.00299	0.00887	CcSEcCtD
Rufinamide—SCN10A—telencephalon—brain cancer	0.00297	0.00826	CbGeAlD
Rufinamide—Pneumonia—Procarbazine—brain cancer	0.0029	0.00861	CcSEcCtD
Rufinamide—Infection—Lomustine—brain cancer	0.00288	0.00855	CcSEcCtD
Rufinamide—Thrombocytopenia—Lomustine—brain cancer	0.00284	0.00842	CcSEcCtD
Rufinamide—SCN4A—pituitary gland—brain cancer	0.00283	0.00788	CbGeAlD
Rufinamide—SCN9A—midbrain—brain cancer	0.0028	0.00779	CbGeAlD
Rufinamide—SCN8A—endocrine gland—brain cancer	0.0028	0.00779	CbGeAlD
Rufinamide—SCN8A—head—brain cancer	0.00276	0.00769	CbGeAlD
Rufinamide—Anorexia—Lomustine—brain cancer	0.00276	0.0082	CcSEcCtD
Rufinamide—Haematuria—Procarbazine—brain cancer	0.00275	0.00817	CcSEcCtD
Rufinamide—SCN9A—spinal cord—brain cancer	0.00273	0.0076	CbGeAlD
Rufinamide—Epistaxis—Procarbazine—brain cancer	0.00272	0.00808	CcSEcCtD
Rufinamide—SCN3A—telencephalon—brain cancer	0.00271	0.00753	CbGeAlD
Rufinamide—SCN11A—brain—brain cancer	0.00264	0.00735	CbGeAlD
Rufinamide—SCN1A—medulla oblongata—brain cancer	0.00264	0.00733	CbGeAlD
Rufinamide—Breast disorder—Hydroxyurea—brain cancer	0.00262	0.00777	CcSEcCtD
Rufinamide—SCN8A—central nervous system—brain cancer	0.00252	0.00702	CbGeAlD
Rufinamide—Decreased appetite—Lomustine—brain cancer	0.00252	0.00748	CcSEcCtD
Rufinamide—SCN2A—pituitary gland—brain cancer	0.00251	0.00698	CbGeAlD
Rufinamide—SCN8A—cerebellum—brain cancer	0.00247	0.00686	CbGeAlD
Rufinamide—SCN2A—medulla oblongata—brain cancer	0.00242	0.00673	CbGeAlD
Rufinamide—SCN10A—pituitary gland—brain cancer	0.00242	0.00673	CbGeAlD
Rufinamide—SCN1A—midbrain—brain cancer	0.00241	0.0067	CbGeAlD
Rufinamide—SCN1A—spinal cord—brain cancer	0.00235	0.00654	CbGeAlD
Rufinamide—Diplopia—Carmustine—brain cancer	0.00234	0.00695	CcSEcCtD
Rufinamide—Neutropenia—Hydroxyurea—brain cancer	0.00234	0.00695	CcSEcCtD
Rufinamide—Dysuria—Hydroxyurea—brain cancer	0.00234	0.00695	CcSEcCtD
Rufinamide—Diplopia—Temozolomide—brain cancer	0.00226	0.00672	CcSEcCtD
Rufinamide—SCN7A—brain—brain cancer	0.00225	0.00625	CbGeAlD
Rufinamide—Infestation—Hydroxyurea—brain cancer	0.00223	0.00663	CcSEcCtD
Rufinamide—Infestation NOS—Hydroxyurea—brain cancer	0.00223	0.00663	CcSEcCtD
Rufinamide—SCN2A—midbrain—brain cancer	0.00221	0.00615	CbGeAlD
Rufinamide—SCN3A—pituitary gland—brain cancer	0.0022	0.00613	CbGeAlD
Rufinamide—Ataxia—Carmustine—brain cancer	0.0022	0.00654	CcSEcCtD
Rufinamide—SCN4A—head—brain cancer	0.00217	0.00603	CbGeAlD
Rufinamide—SCN2A—spinal cord—brain cancer	0.00216	0.006	CbGeAlD
Rufinamide—Ataxia—Temozolomide—brain cancer	0.00213	0.00632	CcSEcCtD
Rufinamide—SCN3A—medulla oblongata—brain cancer	0.00213	0.00592	CbGeAlD
Rufinamide—Tremor—Procarbazine—brain cancer	0.00211	0.00627	CcSEcCtD
Rufinamide—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00211	0.00627	CcSEcCtD
Rufinamide—SCN1A—head—brain cancer	0.00209	0.00581	CbGeAlD
Rufinamide—Anaemia—Procarbazine—brain cancer	0.00208	0.00619	CcSEcCtD
Rufinamide—SCN10A—spinal cord—brain cancer	0.00208	0.00579	CbGeAlD
Rufinamide—Breast disorder—Temozolomide—brain cancer	0.00205	0.00607	CcSEcCtD
Rufinamide—Leukopenia—Procarbazine—brain cancer	0.00202	0.00599	CcSEcCtD
Rufinamide—SCN8A—brain—brain cancer	0.002	0.00557	CbGeAlD
Rufinamide—SCN4A—central nervous system—brain cancer	0.00198	0.0055	CbGeAlD
Rufinamide—CES1—endocrine gland—brain cancer	0.00196	0.00545	CbGeAlD
Rufinamide—Convulsion—Procarbazine—brain cancer	0.00195	0.0058	CcSEcCtD
Rufinamide—SCN3A—midbrain—brain cancer	0.00194	0.00541	CbGeAlD
Rufinamide—SCN2A—endocrine gland—brain cancer	0.00194	0.0054	CbGeAlD
Rufinamide—CES1—head—brain cancer	0.00194	0.00538	CbGeAlD
Rufinamide—SCN2A—head—brain cancer	0.00192	0.00533	CbGeAlD
Rufinamide—Anxiety—Procarbazine—brain cancer	0.00191	0.00568	CcSEcCtD
Rufinamide—SCN1A—central nervous system—brain cancer	0.00191	0.00531	CbGeAlD
Rufinamide—SCN3A—spinal cord—brain cancer	0.0019	0.00528	CbGeAlD
Rufinamide—Neutropenia—Carmustine—brain cancer	0.00189	0.00562	CcSEcCtD
Rufinamide—Bronchitis—Temozolomide—brain cancer	0.00188	0.00558	CcSEcCtD
Rufinamide—SCN10A—endocrine gland—brain cancer	0.00187	0.00521	CbGeAlD
Rufinamide—SCN1A—cerebellum—brain cancer	0.00186	0.00519	CbGeAlD
Rufinamide—SCN10A—head—brain cancer	0.00185	0.00514	CbGeAlD
Rufinamide—Vomiting—Lomustine—brain cancer	0.00184	0.00547	CcSEcCtD
Rufinamide—Dysuria—Temozolomide—brain cancer	0.00183	0.00543	CcSEcCtD
Rufinamide—Neutropenia—Temozolomide—brain cancer	0.00183	0.00543	CcSEcCtD
Rufinamide—Infection—Procarbazine—brain cancer	0.00183	0.00543	CcSEcCtD
Rufinamide—Pneumonia—Carmustine—brain cancer	0.00182	0.00539	CcSEcCtD
Rufinamide—Pollakiuria—Temozolomide—brain cancer	0.00181	0.00536	CcSEcCtD
Rufinamide—Thrombocytopenia—Procarbazine—brain cancer	0.0018	0.00535	CcSEcCtD
Rufinamide—Weight decreased—Temozolomide—brain cancer	0.00177	0.00525	CcSEcCtD
Rufinamide—CES1—central nervous system—brain cancer	0.00177	0.00491	CbGeAlD
Rufinamide—SCN9A—brain—brain cancer	0.00176	0.0049	CbGeAlD
Rufinamide—Pneumonia—Temozolomide—brain cancer	0.00175	0.00521	CcSEcCtD
Rufinamide—Anorexia—Procarbazine—brain cancer	0.00175	0.00521	CcSEcCtD
Rufinamide—SCN2A—central nervous system—brain cancer	0.00175	0.00487	CbGeAlD
Rufinamide—Infestation—Temozolomide—brain cancer	0.00174	0.00518	CcSEcCtD
Rufinamide—Infestation NOS—Temozolomide—brain cancer	0.00174	0.00518	CcSEcCtD
Rufinamide—Nausea—Lomustine—brain cancer	0.00172	0.00511	CcSEcCtD
Rufinamide—SCN2A—cerebellum—brain cancer	0.00171	0.00476	CbGeAlD
Rufinamide—SCN10A—central nervous system—brain cancer	0.00169	0.0047	CbGeAlD
Rufinamide—SCN3A—head—brain cancer	0.00169	0.00469	CbGeAlD
Rufinamide—SCN5A—head—brain cancer	0.00168	0.00468	CbGeAlD
Rufinamide—Insomnia—Procarbazine—brain cancer	0.00166	0.00494	CcSEcCtD
Rufinamide—Hepatobiliary disease—Temozolomide—brain cancer	0.00165	0.0049	CcSEcCtD
Rufinamide—Sinusitis—Temozolomide—brain cancer	0.00164	0.00486	CcSEcCtD
Rufinamide—Somnolence—Procarbazine—brain cancer	0.00164	0.00486	CcSEcCtD
Rufinamide—Anaemia—Hydroxyurea—brain cancer	0.00161	0.00479	CcSEcCtD
Rufinamide—Decreased appetite—Procarbazine—brain cancer	0.0016	0.00475	CcSEcCtD
Rufinamide—Fatigue—Procarbazine—brain cancer	0.00159	0.00471	CcSEcCtD
Rufinamide—Constipation—Procarbazine—brain cancer	0.00157	0.00467	CcSEcCtD
Rufinamide—SCN4A—brain—brain cancer	0.00157	0.00437	CbGeAlD
Rufinamide—Leukopenia—Hydroxyurea—brain cancer	0.00156	0.00464	CcSEcCtD
Rufinamide—Urinary tract disorder—Temozolomide—brain cancer	0.00155	0.00459	CcSEcCtD
Rufinamide—SCN3A—central nervous system—brain cancer	0.00154	0.00428	CbGeAlD
Rufinamide—Urethral disorder—Temozolomide—brain cancer	0.00153	0.00456	CcSEcCtD
Rufinamide—SCN5A—central nervous system—brain cancer	0.00153	0.00427	CbGeAlD
Rufinamide—SCN1A—brain—brain cancer	0.00151	0.00421	CbGeAlD
Rufinamide—Eye disorder—Carmustine—brain cancer	0.00151	0.00449	CcSEcCtD
Rufinamide—Convulsion—Hydroxyurea—brain cancer	0.00151	0.00449	CcSEcCtD
Rufinamide—SCN3A—cerebellum—brain cancer	0.0015	0.00418	CbGeAlD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00148	0.00438	CcSEcCtD
Rufinamide—Neutropenia—Etoposide—brain cancer	0.00146	0.00435	CcSEcCtD
Rufinamide—Eye disorder—Temozolomide—brain cancer	0.00146	0.00434	CcSEcCtD
Rufinamide—Cardiac disorder—Temozolomide—brain cancer	0.00145	0.00431	CcSEcCtD
Rufinamide—Mental disorder—Carmustine—brain cancer	0.00142	0.00421	CcSEcCtD
Rufinamide—Infection—Hydroxyurea—brain cancer	0.00141	0.0042	CcSEcCtD
Rufinamide—Immune system disorder—Temozolomide—brain cancer	0.00141	0.0042	CcSEcCtD
Rufinamide—Mediastinal disorder—Temozolomide—brain cancer	0.00141	0.00419	CcSEcCtD
Rufinamide—Malnutrition—Carmustine—brain cancer	0.00141	0.00419	CcSEcCtD
Rufinamide—Pneumonia—Etoposide—brain cancer	0.0014	0.00417	CcSEcCtD
Rufinamide—CES1—brain—brain cancer	0.0014	0.0039	CbGeAlD
Rufinamide—Nervous system disorder—Hydroxyurea—brain cancer	0.0014	0.00415	CcSEcCtD
Rufinamide—Infestation—Etoposide—brain cancer	0.0014	0.00414	CcSEcCtD
Rufinamide—Infestation NOS—Etoposide—brain cancer	0.0014	0.00414	CcSEcCtD
Rufinamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00139	0.00414	CcSEcCtD
Rufinamide—SCN2A—brain—brain cancer	0.00139	0.00387	CbGeAlD
Rufinamide—Skin disorder—Hydroxyurea—brain cancer	0.00138	0.00411	CcSEcCtD
Rufinamide—Mental disorder—Temozolomide—brain cancer	0.00137	0.00407	CcSEcCtD
Rufinamide—Back pain—Carmustine—brain cancer	0.00136	0.00405	CcSEcCtD
Rufinamide—Malnutrition—Temozolomide—brain cancer	0.00136	0.00405	CcSEcCtD
Rufinamide—Anorexia—Hydroxyurea—brain cancer	0.00136	0.00403	CcSEcCtD
Rufinamide—Hypersensitivity—Procarbazine—brain cancer	0.00136	0.00402	CcSEcCtD
Rufinamide—SCN10A—brain—brain cancer	0.00134	0.00373	CbGeAlD
Rufinamide—Vision blurred—Carmustine—brain cancer	0.00133	0.00395	CcSEcCtD
Rufinamide—Tremor—Carmustine—brain cancer	0.00132	0.00392	CcSEcCtD
Rufinamide—Asthenia—Procarbazine—brain cancer	0.00132	0.00392	CcSEcCtD
Rufinamide—Hepatobiliary disease—Etoposide—brain cancer	0.00132	0.00392	CcSEcCtD
Rufinamide—Back pain—Temozolomide—brain cancer	0.00132	0.00391	CcSEcCtD
Rufinamide—Anaemia—Carmustine—brain cancer	0.0013	0.00387	CcSEcCtD
Rufinamide—Pruritus—Procarbazine—brain cancer	0.0013	0.00386	CcSEcCtD
Rufinamide—Agitation—Carmustine—brain cancer	0.0013	0.00385	CcSEcCtD
Rufinamide—Vision blurred—Temozolomide—brain cancer	0.00128	0.00381	CcSEcCtD
Rufinamide—CYP2E1—telencephalon—brain cancer	0.00128	0.00356	CbGeAlD
Rufinamide—Tremor—Temozolomide—brain cancer	0.00128	0.00379	CcSEcCtD
Rufinamide—Somnolence—Hydroxyurea—brain cancer	0.00127	0.00376	CcSEcCtD
Rufinamide—Leukopenia—Carmustine—brain cancer	0.00126	0.00375	CcSEcCtD
Rufinamide—Anaemia—Temozolomide—brain cancer	0.00126	0.00374	CcSEcCtD
Rufinamide—Diarrhoea—Procarbazine—brain cancer	0.00126	0.00374	CcSEcCtD
Rufinamide—Dyspepsia—Hydroxyurea—brain cancer	0.00125	0.00372	CcSEcCtD
Rufinamide—Agitation—Temozolomide—brain cancer	0.00125	0.00372	CcSEcCtD
Rufinamide—Decreased appetite—Hydroxyurea—brain cancer	0.00124	0.00367	CcSEcCtD
Rufinamide—Urinary tract disorder—Etoposide—brain cancer	0.00124	0.00367	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00123	0.00365	CcSEcCtD
Rufinamide—Urethral disorder—Etoposide—brain cancer	0.00123	0.00365	CcSEcCtD
Rufinamide—Fatigue—Hydroxyurea—brain cancer	0.00123	0.00364	CcSEcCtD
Rufinamide—Vertigo—Temozolomide—brain cancer	0.00122	0.00364	CcSEcCtD
Rufinamide—Convulsion—Carmustine—brain cancer	0.00122	0.00363	CcSEcCtD
Rufinamide—SCN3A—brain—brain cancer	0.00122	0.0034	CbGeAlD
Rufinamide—Leukopenia—Temozolomide—brain cancer	0.00122	0.00362	CcSEcCtD
Rufinamide—SCN5A—brain—brain cancer	0.00122	0.00339	CbGeAlD
Rufinamide—Constipation—Hydroxyurea—brain cancer	0.00122	0.00361	CcSEcCtD
Rufinamide—Dizziness—Procarbazine—brain cancer	0.00122	0.00361	CcSEcCtD
Rufinamide—Anxiety—Carmustine—brain cancer	0.0012	0.00355	CcSEcCtD
Rufinamide—Convulsion—Temozolomide—brain cancer	0.00118	0.00351	CcSEcCtD
Rufinamide—Eye disorder—Etoposide—brain cancer	0.00117	0.00348	CcSEcCtD
Rufinamide—Vomiting—Procarbazine—brain cancer	0.00117	0.00347	CcSEcCtD
Rufinamide—Cardiac disorder—Etoposide—brain cancer	0.00116	0.00345	CcSEcCtD
Rufinamide—Rash—Procarbazine—brain cancer	0.00116	0.00344	CcSEcCtD
Rufinamide—Dermatitis—Procarbazine—brain cancer	0.00116	0.00344	CcSEcCtD
Rufinamide—Anxiety—Temozolomide—brain cancer	0.00116	0.00343	CcSEcCtD
Rufinamide—Headache—Procarbazine—brain cancer	0.00115	0.00342	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00115	0.00342	CcSEcCtD
Rufinamide—Infection—Carmustine—brain cancer	0.00114	0.00339	CcSEcCtD
Rufinamide—Immune system disorder—Etoposide—brain cancer	0.00113	0.00336	CcSEcCtD
Rufinamide—Mediastinal disorder—Etoposide—brain cancer	0.00113	0.00335	CcSEcCtD
Rufinamide—Thrombocytopenia—Carmustine—brain cancer	0.00113	0.00335	CcSEcCtD
Rufinamide—Infection—Temozolomide—brain cancer	0.00111	0.00328	CcSEcCtD
Rufinamide—Anorexia—Carmustine—brain cancer	0.0011	0.00326	CcSEcCtD
Rufinamide—Nausea—Procarbazine—brain cancer	0.00109	0.00324	CcSEcCtD
Rufinamide—Nervous system disorder—Temozolomide—brain cancer	0.00109	0.00324	CcSEcCtD
Rufinamide—Thrombocytopenia—Temozolomide—brain cancer	0.00109	0.00323	CcSEcCtD
Rufinamide—Skin disorder—Temozolomide—brain cancer	0.00108	0.00321	CcSEcCtD
Rufinamide—Anorexia—Temozolomide—brain cancer	0.00106	0.00315	CcSEcCtD
Rufinamide—Back pain—Etoposide—brain cancer	0.00105	0.00313	CcSEcCtD
Rufinamide—Hypersensitivity—Hydroxyurea—brain cancer	0.00105	0.00311	CcSEcCtD
Rufinamide—Insomnia—Carmustine—brain cancer	0.00104	0.00309	CcSEcCtD
Rufinamide—Somnolence—Carmustine—brain cancer	0.00102	0.00304	CcSEcCtD
Rufinamide—Asthenia—Hydroxyurea—brain cancer	0.00102	0.00303	CcSEcCtD
Rufinamide—Anaemia—Etoposide—brain cancer	0.00101	0.00299	CcSEcCtD
Rufinamide—Insomnia—Temozolomide—brain cancer	0.00101	0.00299	CcSEcCtD
Rufinamide—CYP2E1—medulla oblongata—brain cancer	0.001	0.00279	CbGeAlD
Rufinamide—Decreased appetite—Carmustine—brain cancer	0.001	0.00297	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Carmustine—brain cancer	0.000994	0.00295	CcSEcCtD
Rufinamide—Somnolence—Temozolomide—brain cancer	0.000989	0.00294	CcSEcCtD
Rufinamide—Constipation—Carmustine—brain cancer	0.000984	0.00292	CcSEcCtD
Rufinamide—Vertigo—Etoposide—brain cancer	0.00098	0.00291	CcSEcCtD
Rufinamide—Dyspepsia—Temozolomide—brain cancer	0.000979	0.00291	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—brain cancer	0.000976	0.0029	CcSEcCtD
Rufinamide—ALB—brain—brain cancer	0.000975	0.00271	CbGeAlD
Rufinamide—Diarrhoea—Hydroxyurea—brain cancer	0.000974	0.00289	CcSEcCtD
Rufinamide—Decreased appetite—Temozolomide—brain cancer	0.000967	0.00287	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.00096	0.00285	CcSEcCtD
Rufinamide—Fatigue—Temozolomide—brain cancer	0.000959	0.00285	CcSEcCtD
Rufinamide—Constipation—Temozolomide—brain cancer	0.000951	0.00282	CcSEcCtD
Rufinamide—Convulsion—Etoposide—brain cancer	0.000945	0.00281	CcSEcCtD
Rufinamide—Dizziness—Hydroxyurea—brain cancer	0.000942	0.0028	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000922	0.00274	CcSEcCtD
Rufinamide—Vomiting—Hydroxyurea—brain cancer	0.000905	0.00269	CcSEcCtD
Rufinamide—Rash—Hydroxyurea—brain cancer	0.000898	0.00267	CcSEcCtD
Rufinamide—Dermatitis—Hydroxyurea—brain cancer	0.000897	0.00266	CcSEcCtD
Rufinamide—CYP2E1—spinal cord—brain cancer	0.000896	0.00249	CbGeAlD
Rufinamide—Headache—Hydroxyurea—brain cancer	0.000892	0.00265	CcSEcCtD
Rufinamide—Infection—Etoposide—brain cancer	0.000884	0.00263	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—brain cancer	0.000872	0.00259	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—brain cancer	0.000865	0.00257	CcSEcCtD
Rufinamide—Anorexia—Etoposide—brain cancer	0.000848	0.00252	CcSEcCtD
Rufinamide—Hypersensitivity—Carmustine—brain cancer	0.000848	0.00252	CcSEcCtD
Rufinamide—Nausea—Hydroxyurea—brain cancer	0.000846	0.00251	CcSEcCtD
Rufinamide—Asthenia—Carmustine—brain cancer	0.000826	0.00245	CcSEcCtD
Rufinamide—Hypersensitivity—Temozolomide—brain cancer	0.00082	0.00243	CcSEcCtD
Rufinamide—CYP2E1—endocrine gland—brain cancer	0.000806	0.00224	CbGeAlD
Rufinamide—Asthenia—Temozolomide—brain cancer	0.000798	0.00237	CcSEcCtD
Rufinamide—CYP2E1—head—brain cancer	0.000796	0.00221	CbGeAlD
Rufinamide—Somnolence—Etoposide—brain cancer	0.000791	0.00235	CcSEcCtD
Rufinamide—Diarrhoea—Carmustine—brain cancer	0.000788	0.00234	CcSEcCtD
Rufinamide—Pruritus—Temozolomide—brain cancer	0.000787	0.00234	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—brain cancer	0.000774	0.0023	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000768	0.00228	CcSEcCtD
Rufinamide—Fatigue—Etoposide—brain cancer	0.000767	0.00228	CcSEcCtD
Rufinamide—Dizziness—Carmustine—brain cancer	0.000761	0.00226	CcSEcCtD
Rufinamide—Constipation—Etoposide—brain cancer	0.000761	0.00226	CcSEcCtD
Rufinamide—Diarrhoea—Temozolomide—brain cancer	0.000761	0.00226	CcSEcCtD
Rufinamide—Dizziness—Temozolomide—brain cancer	0.000736	0.00218	CcSEcCtD
Rufinamide—Vomiting—Carmustine—brain cancer	0.000732	0.00217	CcSEcCtD
Rufinamide—CYP2E1—central nervous system—brain cancer	0.000727	0.00202	CbGeAlD
Rufinamide—Rash—Carmustine—brain cancer	0.000726	0.00215	CcSEcCtD
Rufinamide—Dermatitis—Carmustine—brain cancer	0.000725	0.00215	CcSEcCtD
Rufinamide—Headache—Carmustine—brain cancer	0.000721	0.00214	CcSEcCtD
Rufinamide—CYP2E1—cerebellum—brain cancer	0.00071	0.00198	CbGeAlD
Rufinamide—Vomiting—Temozolomide—brain cancer	0.000707	0.0021	CcSEcCtD
Rufinamide—Rash—Temozolomide—brain cancer	0.000701	0.00208	CcSEcCtD
Rufinamide—Dermatitis—Temozolomide—brain cancer	0.000701	0.00208	CcSEcCtD
Rufinamide—Headache—Temozolomide—brain cancer	0.000697	0.00207	CcSEcCtD
Rufinamide—Nausea—Carmustine—brain cancer	0.000684	0.00203	CcSEcCtD
Rufinamide—Nausea—Temozolomide—brain cancer	0.000661	0.00196	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—brain cancer	0.000656	0.00195	CcSEcCtD
Rufinamide—CYP3A4—endocrine gland—brain cancer	0.000649	0.0018	CbGeAlD
Rufinamide—Asthenia—Etoposide—brain cancer	0.000639	0.0019	CcSEcCtD
Rufinamide—Pruritus—Etoposide—brain cancer	0.00063	0.00187	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—SMO—brain cancer	0.000614	0.00619	CbGpPWpGaD
Rufinamide—Diarrhoea—Etoposide—brain cancer	0.000609	0.00181	CcSEcCtD
Rufinamide—CES1—Fluoropyrimidine Activity—TP53—brain cancer	0.000602	0.00608	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—OR4C12—brain cancer	0.000591	0.00596	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—OR14C36—brain cancer	0.000591	0.00596	CbGpPWpGaD
Rufinamide—Dizziness—Etoposide—brain cancer	0.000589	0.00175	CcSEcCtD
Rufinamide—CYP3A4—central nervous system—brain cancer	0.000585	0.00163	CbGeAlD
Rufinamide—SCN8A—Axon guidance—TRPC6—brain cancer	0.000579	0.00584	CbGpPWpGaD
Rufinamide—CYP2E1—brain—brain cancer	0.000577	0.0016	CbGeAlD
Rufinamide—CES1—E2F transcription factor network—CDKN2A—brain cancer	0.000573	0.00578	CbGpPWpGaD
Rufinamide—Vomiting—Etoposide—brain cancer	0.000566	0.00168	CcSEcCtD
Rufinamide—Rash—Etoposide—brain cancer	0.000561	0.00167	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—brain cancer	0.000561	0.00166	CcSEcCtD
Rufinamide—Headache—Etoposide—brain cancer	0.000558	0.00166	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—ABR—brain cancer	0.000557	0.00562	CbGpPWpGaD
Rufinamide—Nausea—Etoposide—brain cancer	0.000529	0.00157	CcSEcCtD
Rufinamide—SCN7A—Developmental Biology—TRPC6—brain cancer	0.000507	0.00512	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—ABR—brain cancer	0.000506	0.0051	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DTX2—brain cancer	0.000503	0.00507	CbGpPWpGaD
Rufinamide—SCN7A—L1CAM interactions—EGFR—brain cancer	0.000482	0.00486	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—TRPC6—brain cancer	0.000469	0.00473	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TRPC6—brain cancer	0.000452	0.00456	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—TRPC6—brain cancer	0.000448	0.00452	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000435	0.00438	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—TRPC6—brain cancer	0.000431	0.00434	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—TRPC6—brain cancer	0.000431	0.00434	CbGpPWpGaD
Rufinamide—SCN11A—L1CAM interactions—EGFR—brain cancer	0.000429	0.00433	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—TRPC6—brain cancer	0.000415	0.00419	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—TRPC6—brain cancer	0.000415	0.00419	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TRPC6—brain cancer	0.000413	0.00417	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000411	0.00415	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000406	0.00409	CbGpPWpGaD
Rufinamide—SCN8A—L1CAM interactions—EGFR—brain cancer	0.000393	0.00396	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—MYC—brain cancer	0.000389	0.00392	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000381	0.00385	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTCH2—brain cancer	0.000381	0.00384	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000376	0.0038	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HES5—brain cancer	0.000369	0.00372	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STRADA—brain cancer	0.000358	0.00361	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TRPC6—brain cancer	0.000353	0.00356	CbGpPWpGaD
Rufinamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000349	0.00352	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000338	0.00341	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000338	0.0034	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TRPC6—brain cancer	0.000334	0.00337	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000333	0.00336	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—SHH—brain cancer	0.000332	0.00335	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HES1—brain cancer	0.000327	0.0033	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TRPC6—brain cancer	0.00032	0.00323	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TRPC6—brain cancer	0.00032	0.00323	CbGpPWpGaD
Rufinamide—SCN9A—L1CAM interactions—EGFR—brain cancer	0.000317	0.0032	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—SMO—brain cancer	0.000315	0.00318	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PTCH1—brain cancer	0.000315	0.00318	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000311	0.00314	CbGpPWpGaD
Rufinamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00031	0.00312	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TRPC6—brain cancer	0.000307	0.0031	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TRPC6—brain cancer	0.000307	0.0031	CbGpPWpGaD
Rufinamide—SCN3A—L1CAM interactions—EGFR—brain cancer	0.000304	0.00306	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ABR—brain cancer	0.000299	0.00302	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TRPC6—brain cancer	0.000296	0.00299	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TRPC6—brain cancer	0.000296	0.00299	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—TRPC6—brain cancer	0.000292	0.00294	CbGpPWpGaD
Rufinamide—SCN2A—L1CAM interactions—EGFR—brain cancer	0.000292	0.00294	CbGpPWpGaD
Rufinamide—SCN4A—L1CAM interactions—EGFR—brain cancer	0.000292	0.00294	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HES1—brain cancer	0.000291	0.00294	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GLI2—brain cancer	0.000289	0.00291	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000283	0.00286	CbGpPWpGaD
Rufinamide—SCN10A—L1CAM interactions—EGFR—brain cancer	0.000281	0.00284	CbGpPWpGaD
Rufinamide—SCN1A—L1CAM interactions—EGFR—brain cancer	0.000281	0.00284	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GLI1—brain cancer	0.000271	0.00274	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HES1—brain cancer	0.000266	0.00269	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—VAV1—brain cancer	0.000264	0.00267	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—ERBB2—brain cancer	0.000263	0.00265	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SUFU—brain cancer	0.000257	0.0026	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CDK4—brain cancer	0.000256	0.00259	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—SOD2—brain cancer	0.000253	0.00255	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GFAP—brain cancer	0.000248	0.0025	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—VAV1—brain cancer	0.00024	0.00242	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HEY1—brain cancer	0.000235	0.00237	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—ERBB2—brain cancer	0.000234	0.00236	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DLL1—brain cancer	0.000231	0.00233	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CDK4—brain cancer	0.000228	0.0023	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HES1—brain cancer	0.000215	0.00217	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—ERBB2—brain cancer	0.000214	0.00216	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CDK4—brain cancer	0.000209	0.00211	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TRPC6—brain cancer	0.000208	0.0021	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HES1—brain cancer	0.000206	0.00208	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—VEGFA—brain cancer	0.000202	0.00204	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000201	0.00203	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HES1—brain cancer	0.000198	0.002	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HES1—brain cancer	0.000198	0.002	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—EGFR—brain cancer	0.000198	0.002	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SHH—brain cancer	0.000196	0.00198	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HES1—brain cancer	0.000191	0.00193	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HES1—brain cancer	0.000191	0.00193	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TRPC6—brain cancer	0.000189	0.00191	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—RELA—brain cancer	0.000189	0.0019	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—ERBB2—brain cancer	0.000187	0.00189	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SMO—brain cancer	0.000186	0.00188	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTCH1—brain cancer	0.000186	0.00188	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—EGFR—brain cancer	0.000182	0.00184	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—VEGFA—brain cancer	0.00018	0.00182	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.00018	0.00181	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000177	0.00179	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000175	0.00176	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MPL—brain cancer	0.000174	0.00176	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—ERBB2—brain cancer	0.000173	0.00175	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000169	0.00171	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CDK4—brain cancer	0.000169	0.0017	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—RELA—brain cancer	0.000168	0.0017	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CG—brain cancer	0.000168	0.00169	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—ERBB2—brain cancer	0.000167	0.00168	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—S100A10—brain cancer	0.000167	0.00168	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—ERBB2—brain cancer	0.000166	0.00167	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—brain cancer	0.000165	0.00166	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CTNNB1—brain cancer	0.000164	0.00165	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—EGFR—brain cancer	0.000162	0.00164	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CDK4—brain cancer	0.000162	0.00163	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—ERBB2—brain cancer	0.000159	0.0016	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—ERBB2—brain cancer	0.000159	0.0016	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CDK4—brain cancer	0.000155	0.00157	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CDK4—brain cancer	0.000155	0.00157	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—RELA—brain cancer	0.000154	0.00155	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—ERBB2—brain cancer	0.000153	0.00155	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—ERBB2—brain cancer	0.000153	0.00155	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—ERBB2—brain cancer	0.000153	0.00154	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CG—brain cancer	0.000152	0.00154	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CDK4—brain cancer	0.00015	0.00151	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CDK4—brain cancer	0.00015	0.00151	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.00015	0.00151	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000149	0.0015	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOTCH2—brain cancer	0.000149	0.0015	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—EGFR—brain cancer	0.000148	0.0015	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—RELA—brain cancer	0.000146	0.00147	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CTNNB1—brain cancer	0.000146	0.00147	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000144	0.00146	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—brain cancer	0.000144	0.00146	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—STAT3—brain cancer	0.000143	0.00144	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VAV1—brain cancer	0.000142	0.00143	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HES1—brain cancer	0.000134	0.00135	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CTNNB1—brain cancer	0.000134	0.00135	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—brain cancer	0.000133	0.00134	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL2—brain cancer	0.000132	0.00133	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EGFR—brain cancer	0.00013	0.00131	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—brain cancer	0.000129	0.0013	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—brain cancer	0.000128	0.00129	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—STAT3—brain cancer	0.000127	0.00128	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000126	0.00127	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—RELA—brain cancer	0.000124	0.00125	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ERBB2—brain cancer	0.000124	0.00125	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—brain cancer	0.000123	0.00124	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—brain cancer	0.000123	0.00124	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HES1—brain cancer	0.000122	0.00123	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—brain cancer	0.00012	0.00121	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—RELA—brain cancer	0.000119	0.0012	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ERBB2—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—IL2—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—BSG—brain cancer	0.000118	0.00119	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—STAT3—brain cancer	0.000116	0.00117	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PDGFRA—brain cancer	0.000116	0.00117	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000116	0.00117	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—brain cancer	0.000116	0.00117	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—brain cancer	0.000115	0.00116	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—RELA—brain cancer	0.000114	0.00115	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—RELA—brain cancer	0.000114	0.00115	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ERBB2—brain cancer	0.000113	0.00114	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ERBB2—brain cancer	0.000113	0.00114	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SPP1—brain cancer	0.000113	0.00114	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000112	0.00113	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—brain cancer	0.00011	0.00111	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—brain cancer	0.00011	0.00111	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—RELA—brain cancer	0.00011	0.00111	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—RELA—brain cancer	0.00011	0.00111	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ERBB2—brain cancer	0.000109	0.0011	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ERBB2—brain cancer	0.000109	0.0011	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CTNNB1—brain cancer	0.000108	0.00109	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ERBB2—brain cancer	0.000108	0.00109	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL2—brain cancer	0.000107	0.00108	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—brain cancer	0.000106	0.00107	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—brain cancer	0.000106	0.00107	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—brain cancer	0.000106	0.00107	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CDK4—brain cancer	0.000105	0.00106	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—brain cancer	0.000103	0.00104	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IRS2—brain cancer	0.000102	0.00103	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—brain cancer	9.93e-05	0.001	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—brain cancer	9.93e-05	0.001	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—brain cancer	9.59e-05	0.000967	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—brain cancer	9.58e-05	0.000966	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—brain cancer	9.58e-05	0.000966	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—brain cancer	9.51e-05	0.00096	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—STAT3—brain cancer	9.42e-05	0.00095	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.2e-05	0.000929	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	9.14e-05	0.000922	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—brain cancer	9.1e-05	0.000918	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—STAT3—brain cancer	9.01e-05	0.000909	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APC—brain cancer	9e-05	0.000908	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CG—brain cancer	9e-05	0.000908	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—brain cancer	8.74e-05	0.000882	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—brain cancer	8.74e-05	0.000882	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—STAT3—brain cancer	8.66e-05	0.000873	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—STAT3—brain cancer	8.66e-05	0.000873	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—brain cancer	8.56e-05	0.000864	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—brain cancer	8.45e-05	0.000853	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—brain cancer	8.43e-05	0.00085	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—brain cancer	8.43e-05	0.00085	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—STAT3—brain cancer	8.35e-05	0.000842	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—STAT3—brain cancer	8.35e-05	0.000842	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—brain cancer	8.3e-05	0.000838	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—brain cancer	8.2e-05	0.000827	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—brain cancer	8.19e-05	0.000826	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—brain cancer	7.87e-05	0.000794	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—brain cancer	7.87e-05	0.000794	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—RELA—brain cancer	7.74e-05	0.000781	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TRPC6—brain cancer	7.71e-05	0.000777	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ERBB2—brain cancer	7.69e-05	0.000776	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—brain cancer	7.59e-05	0.000765	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—brain cancer	7.59e-05	0.000765	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—brain cancer	7.47e-05	0.000754	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	7.11e-05	0.000718	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RELA—brain cancer	7.03e-05	0.00071	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—brain cancer	6.99e-05	0.000705	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—brain cancer	6.73e-05	0.000679	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	6.67e-05	0.000673	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2C9—brain cancer	6.52e-05	0.000658	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—brain cancer	6.33e-05	0.000639	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—brain cancer	6.18e-05	0.000623	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—brain cancer	6.12e-05	0.000617	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—brain cancer	5.93e-05	0.000598	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—brain cancer	5.87e-05	0.000592	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VAV1—brain cancer	5.77e-05	0.000582	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2C9—brain cancer	5.61e-05	0.000566	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BSG—brain cancer	5.55e-05	0.00056	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—brain cancer	5.38e-05	0.000543	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—brain cancer	5.33e-05	0.000538	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—brain cancer	5.33e-05	0.000538	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	5.01e-05	0.000505	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—brain cancer	4.95e-05	0.0005	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—brain cancer	4.85e-05	0.000489	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH1—brain cancer	4.77e-05	0.000481	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BSG—brain cancer	4.77e-05	0.000481	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.25e-05	0.000429	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH1—brain cancer	4.1e-05	0.000414	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—brain cancer	4.07e-05	0.00041	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—brain cancer	3.77e-05	0.00038	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—brain cancer	3.67e-05	0.00037	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.34e-05	0.000337	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—brain cancer	3.24e-05	0.000327	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2C9—brain cancer	3.03e-05	0.000305	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—brain cancer	2.58e-05	0.00026	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BSG—brain cancer	2.57e-05	0.00026	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH1—brain cancer	2.21e-05	0.000223	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—brain cancer	2.19e-05	0.000221	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—brain cancer	1.75e-05	0.000176	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—brain cancer	1.73e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—brain cancer	1.66e-05	0.000167	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—brain cancer	1.49e-05	0.00015	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—brain cancer	8.02e-06	8.1e-05	CbGpPWpGaD
